Posttranscriptional Inhibition of Gene Expression by Mycobacterium tuberculosis Offsets Transcriptional Synergism with IFN-γ and Posttranscriptional Up-Regulation by IFN-γ

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 2935-2943

  Qiao, Yaming ^a   Prabhakar, Savita ^a   Canova, Antony ^a   Hoshino, Yoshihiko ^b   Weiden, Michael ^b   Pine, Richard ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOPLASM PROTEIN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; MESSENGER RNA; NUCLEAR RNA; POLYADENYLATED RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASMIC RNA; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; INTERFERON PRODUCTION; MONOCYTE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RNA ANALYSIS; TRANSCRIPTION REGULATION;

EID: 1342324690     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.2935     Document Type: Article

References (55)

1. Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009.
2. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
3. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in IFNγ gene-disrupted mice. J. Exp. Med. 178:2243.
4. Dupuis, S., R. Doffinger, C. Picard, C. Fieschi, F. Altare, E. Jouanguy, L. Abel, and J. L. Casanova. 2000. Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol. Rev. 178:129.
5. Dupuis, S., E. Jouanguy, S. Al-Hajjar, C. Fieschi, I. Z. Al-Mohsen, S. Al-Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, et al. 2003. Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388.
6. Dupuis, S., C. Dargemont, C. Fieschi, N. Thomassin, S. Rosenzweig, J. Harris, S. M. Holland, R. D. Schreiber, and J. L. Casanova. 2001. Impairment of mycobacterial but not viral immunity by a germline human STATI mutation. Science 293:300.
7. Barnes, P. F., S.-J. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor mecrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol. 145:149.
8. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482.
9. Condos, R., W. N. Rom, Y. M. Liu, and N. W. Schluger. 1998. Local immune responses correlate with presentation and outcome in tuberculosis. Am. J. Respir. Crit. Care Med. 157:729.
10. Nathan, C. F., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. 1983. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670.
11. Murray, H. W., A. M. Granger, and R. F. Teitelbaum. 1991. γ Interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron. Infect. Immun. 59:4684.
12. Thomas, S. M., L. F. Garrity, C. R. Brandt, C. S. Schobert, G. S. Feng, M. W. Taylor, J. M. Carlin, and G. I. Byrne. 1993. IFN-γ-mediated antimicrobial response: indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J. Immunol. 150:5529.
13. Rook, G. A., J. Steele, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant γ-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333.
14. Steele, J., K. C. Flint, A. L. Pozniak, B. Hudspith, M. M. Johnson, and G. A. Rook. 1986. Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant γ interferon. Tubercle 67:289,
15. Ting, L. M., A. C. Kim, A. Cattamanchi, and J. D. Ernst. 1999. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163:3898.
16. Ehrt, S., D. Schnappinger, S. Bekiranov, I. Drenkow, S. Shi, T. R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194:1123.
17. Kincaid, E. Z., and J. D. Ernst. 2003. Mycobacterium tuberculosis exerts gene-selective inhibition of transcriptional responses to IFN-γ without inhibiting STAT1 function. J. Immunol. 171:2042.
18. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749.
19. Ramana, C. V., M. P. Gil, Y. Han, R. M. Ransohoff, R. D. Schreiber, and G. R. Stark. 2001. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl. Acad. Sci. USA 98:6674.
20. Pine, R., T. Decker, D. S. Kessler, D. E. Levy, and J. E. Darnell, Jr. 1990. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both β interferon- and interferon-stimulated genes but is not a primary transriptional activator of either. Mol. Cell. Biol. 10:2448.
21. Cooper, A. M., J. E. Pearl, J. V. Brooks, S. Ehlers, and I. M. Orme. 2000. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68:6879.
22. Yamada, H., S. Mizuno, and I. Sugawara. 2002. Interferon regulatory factor 1 in mycobacterial infection. Microbiol. Immunol. 46:751.
23. Pine, R. 2002. Review: IRF and tuberculosis. J. Interferon Cytokine Res. 22:15.
24. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, et al. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612.
25. Martin, E., C. Nathan, and Q.-W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med 180:977.
26. phox expression. J. Biol. Chem. 273:13957.
27. phox expression. J. Immunol. 163:6095.
28. Tzoanopoulos, D., M. Speletas, K. Arvanitidis, C. Veiopoulou, S. Kyriaki, G. Thyphronitis, P. Sideras, G. Kartalis, and K. Ritis. 2002. Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukemia. Br. J. Haematol. 119:46.
29. Harada, H., T. Kondo, S. Ogawa, T. Tamura, M. Kitagawa, N. Tanaka, M. S. Lamphier, H. Hirai, and T. Taniguchi. 1994. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene 9:3313.
30. Harroch, S., Y. Gothelf, N. Watanabe, M. Revel, and J. Chebath. 1993. Interleukin-6 activates and regulates transcription factors of the interferon regulatory factor family in M1 cells. J. Biol. Chem. 268:9092.
31. Qiao, Y., S. Prabhakar, E. M. Coccia, M. Weiden, A. Canova, E. Giacomini, and R. Pine. 2002. Host defense responses to infection by Mycobacterium tuberculosis: induction of IRF-1 and a serine protease inhibitor. J. Biol. Chem. 277:22377.
32. Remoli, M. E., E. Giacomini, G. Lutfalla, E. Dondi, G. Orefici, A. Battistini, G. Uze, S. Pellegrini, and E. M. Coccia. 2002. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J. Immunol. 169:366.
33. Friedman, C. R., G. C. Quinn, B. N. Kreiswirth, D. C. Perlman, N. Salomon, N. Schluger, M. Lutfey, J. Berger, N. Poltoratskaia, and L. W. Riley. 1997. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J. Infect. Dis. 176:478.
34. Zhao, B. Y., R. Pine, J. Domagala, and K. Drlica. 1999. Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages. Antimicrob. Agents Chemother. 43:661.
35. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171.
36. Weiden, M., N. Tanaka, Y. Qiao, B. Y. Zhao, Y. Honda, K. Nakata, A. Canova, D. E. Levy, W. N. Rom, and R. Pine. 2000. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein β expression. J. Immunol. 165:2028.
37. Prabhakar, S., Y. Qiao, Y. Hoshino, M. Weiden, A. Canova, E. Giacomini, E. Coccia, and R. Pine. 2003. Inhibition of response to α interferon by Mycobacterium tuberculosis. Infect. Immun. 71:2487.
38. Tsuchiya, S., Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, and K. Tada. 1982. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42:1530.
39. Riendeau, C. J., and H. Kornfeld. 2003. THP-1 cell apoptosis in response to mycobacterial infection. Infect. Immun. 71:254.
40. Pine, R. 1997. Convergence of TNFα and IFNγ signaling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/κB promoter element. Nucleic Acids Res. 21:4346.
41. Reich, N., B. Evans, D. Levy, D. Fahey, E. Knight, Jr., and J. E. Darnell, Jr. 1987. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA 84:6394.
42. Sladek, F. M., W. Zhong, E. Lai, and J. E. Darnell, Jr. 1990. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4:2353.
43. Larner, A. C., G. Jonak, Y.-S. E. Cheng, B. Korant, E. Knight, and J. E. Darnell, Jr. 1984. Transcriptional induction of two genes in human cells by β interferon. Proc. Natl. Acad. Sci. USA 81:6733.
44. Tyagi, S., and F. R. Kramer. 1996. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 14:303.
45. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN α and IFN γ, and is likely to autoregulate the p91 gene. EMBO J. 13:158.
46. Comber, P. G., V. Lentz, and A. D. Schreiber. 1992. Modulation of the transcriptional rate of Fcγ receptor mRNA in human mononuclear phagocytes. Cell. Immunol. 145:324.
47. Condino-Neto, A., and P. E. Newburger. 2000. Interferon-γ improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood 95:3548.
48. Ishibashi, F., T. Mizukami, S. Kanegasaki, L. Motoda, R. Kakinuma, F. Endo, and H. Nunoi. 2001. Improved superoxide-generating ability by interferon γ due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene. Blood 98:436.
49. Snyder, S. R., J. F. Waring, S. Z. Zhu, S. Kaplan, J. Schultz, and G. D. Ginder, 2001. A 3′-transcribed region of the HLA-A2 gene mediates posttranscriptional stimulation by IFN-γ. J. Immunol. 166:3966.
50. Bourgeade, M. F., F. Silbermann, L. Kuhn, U. Testa, C. Peschle, S. Memet, M. N. Thang, and F. Besancon. 1992. Post-transcriptional regulation of transferrin receptor mRNA by IFN γ. Nucleic Acids Res. 20:2997.
51. Gehring, A. J., R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom. 2003. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits γ interferon-regulated HLA-DR and FcγR1 on human macrophages through Toll-like receptor 2. Infect. Immun. 71:4487.
52. Pai, R. K., M. Convery, T. A. Hamilton, W. H. Boom, and C. V. Harding. 2003. Inhibition of IFN-γ-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 171:175.
53. Alexander, W. S. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2:410.
54. Stoiber, D., P. Kovarik, S. Cohney, J. A. Johnston, P. Steinlein, and T. Decker. 1999. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ. J. Immunol. 163:2640.
55. Ohmori, Y., R. D. Schreiber, and T. A. Hamilton. 1997. Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J. Biol. Chem. 272:14899.